Skip to content

F&P Toffee Full Face Mask Clinical Trial, NZ, 2020

F&P Toffee Full Face Mask Clinical Trial, NZ, 2020

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT04615832
Enrollment
44
Registered
2020-11-04
Start date
2020-11-10
Completion date
2021-03-31
Last updated
2021-12-01

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Obstructive Sleep Apnea, Positive Airway Pressure Therapy

Brief summary

This will be a prospective, multi-arm, randomized, and non-blinded clinical trial designed to evaluate the performance, comfort, and usability of the Toffee full face mask amongst participants who have been prescribed PAP therapy by a physician. This clinical trial will take place across three investigation sites with a sample of 45 participants.

Detailed description

The purpose of this clinical investigation was to evaluate the performance, comfort and ease of use of the F&P Toffee Full Face Mask. The clinical investigation took place across three sites in order to recruit the required number of participants. The clinical investigation tested the mask on 44 participants, who were currently using a full face mask for PAP therapy. This was a non-randomized non-blinded single intervention study. Informed consent was gathered from the 44 participants before demographic and baseline measurements were recorded. Participants were issued an appropriate fitting Toffee Full face mask for the two week at home trial. After two weeks the participants returned the masks. At this visit device data was downloaded and participant questionnaires were completed.

Interventions

Full face mask for PAP therapy applied in a home environment

Sponsors

Fisher and Paykel Healthcare
Lead SponsorINDUSTRY

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
22 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Persons who are ≥ 22 years of age * Persons who weigh ≥ 66 lbs (30 kgs) * Persons who have been prescribed PAP (APAP, BPAP or CPAP) therapy by a physician * Persons who are compliant with PAP therapy for ≥ 4 hours per night for 70% of nights for at least two weeks prior to enrolment in the trial * Persons who are currently using a full face mask * Persons who have an IPAP pressure of \< 30 cmH2O * Persons who currently use a PAP therapy device with data recording capabilities * Persons who are fluent in spoken and written English * Persons who possess the capacity to provide informed consent

Exclusion criteria

* Persons who are intolerant to PAP therapy * Persons who are required to use PAP therapy for more than 12 hours per day or for extensive periods other than sleep or naps * Persons using nasal or nasal pillows masks * Persons who possess, or suffer from, anatomical or physiological conditions which make PAP therapy inappropriate * Persons who are pregnant or think they may be pregnant * Persons who use a PAP therapy machine for the delivery of medicines, except supplemental O2 * Persons who currently have cold or flu like symptoms at the time of recruitment * Persons who have tested positive for COVID-19 within the previous 28 days prior to enrolment

Design outcomes

Primary

MeasureTime frameDescription
Comfort - SubjectiveAssessed 2 weeks after mask fittingTo assess the comfort of the mask as experienced by the participant. Comfort will be measured on a 4 point likert type scale (options: Very Uncomfortable, Uncomfortable, Comfortable, and Very Comfortable). Very Comfortable will be scored the highest and Very Uncomfortable will be scored the lowest. Different aspects of the mask such as cushion comfort, headgear comfort and overall comfort will be assessed using the same scale. Questions will be asked on a questionnaire and further qualitative responses will be captured during an interview.
UsabilityAssessed 2 weeks after mask fittingTo assess the ease of use of the mask as experienced by the participant. Questions regarding the freedom of movement in bed will be asked using a 4 point likert type scale (options: Very Difficult, Difficult, Easy, and Very Easy). Very Easy will be scored the highest and Very Difficult will be scored the lowest. Questions will be asked via a questionnaire with additional qualitative responses captured during an interview.
Seal PerformanceAssessed 2 weeks after mask fittingTo assess the sealing performance of the mask when used in a home environment. Questions regarding the seal performance will be asked using a 4 point likert type scale (options: Very poor, Poor, Good, and Very good). Very good will be scored the highest and Very poor will be scored the lowest.

Countries

New Zealand

Participant flow

Participants by arm

ArmCount
Toffee Full Face Mask
Toffee Full Face Mask: Full face mask for PAP therapy applied in a home environment
44
Total44

Baseline characteristics

CharacteristicToffee Full Face Mask
Age, Categorical
<=18 years
0 Participants
Age, Categorical
>=65 years
0 Participants
Age, Categorical
Between 18 and 65 years
44 Participants
Ethnicity (NIH/OMB)
Hispanic or Latino
1 Participants
Ethnicity (NIH/OMB)
Not Hispanic or Latino
43 Participants
Ethnicity (NIH/OMB)
Unknown or Not Reported
0 Participants
Region of Enrollment
New Zealand
44 Participants
Sex: Female, Male
Female
12 Participants
Sex: Female, Male
Male
32 Participants

Adverse events

Event typeEG000
affected / at risk
deaths
Total, all-cause mortality
0 / 44
other
Total, other adverse events
10 / 44
serious
Total, serious adverse events
0 / 44

Outcome results

Primary

Comfort - Subjective

To assess the comfort of the mask as experienced by the participant. Comfort will be measured on a 4 point likert type scale (options: Very Uncomfortable, Uncomfortable, Comfortable, and Very Comfortable). Very Comfortable will be scored the highest and Very Uncomfortable will be scored the lowest. Different aspects of the mask such as cushion comfort, headgear comfort and overall comfort will be assessed using the same scale. Questions will be asked on a questionnaire and further qualitative responses will be captured during an interview.

Time frame: Assessed 2 weeks after mask fitting

ArmMeasureGroupValue (COUNT_OF_PARTICIPANTS)
Toffee Full Face MaskComfort - SubjectiveVery comfortable18 Participants
Toffee Full Face MaskComfort - SubjectiveUncomfortable2 Participants
Toffee Full Face MaskComfort - SubjectiveComfortable23 Participants
Toffee Full Face MaskComfort - SubjectiveVery uncomfortable1 Participants
Primary

Seal Performance

To assess the sealing performance of the mask when used in a home environment. Questions regarding the seal performance will be asked using a 4 point likert type scale (options: Very poor, Poor, Good, and Very good). Very good will be scored the highest and Very poor will be scored the lowest.

Time frame: Assessed 2 weeks after mask fitting

ArmMeasureGroupValue (COUNT_OF_PARTICIPANTS)
Toffee Full Face MaskSeal PerformanceVery poor0 Participants
Toffee Full Face MaskSeal PerformancePoor4 Participants
Toffee Full Face MaskSeal PerformanceVery good25 Participants
Toffee Full Face MaskSeal PerformanceGood15 Participants
Primary

Usability

To assess the ease of use of the mask as experienced by the participant. Questions regarding the freedom of movement in bed will be asked using a 4 point likert type scale (options: Very Difficult, Difficult, Easy, and Very Easy). Very Easy will be scored the highest and Very Difficult will be scored the lowest. Questions will be asked via a questionnaire with additional qualitative responses captured during an interview.

Time frame: Assessed 2 weeks after mask fitting

ArmMeasureGroupValue (COUNT_OF_PARTICIPANTS)
Toffee Full Face MaskUsabilityVery easy19 Participants
Toffee Full Face MaskUsabilityEasy23 Participants
Toffee Full Face MaskUsabilityDifficult2 Participants
Toffee Full Face MaskUsabilityVery difficult0 Participants

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026